Produto adicionado correctamente ao carrinho.

discount label
H-GFQSMYTFV-OH
Ver 3D

Biosynth logo

H-GFQSMYTFV-OH

Ref. 3D-PP43921

1mg
217,00 €
10mg
253,00 €
100mg
455,00 €
Entrega estimada em Estados Unidos, Sexta-feira 27 de Dezembro de 2024

Informação sobre produto

Nome:
H-GFQSMYTFV-OH
Sinónimos:
  • NH2-Gly-Phe-Gln-Ser-Met-Tyr-Thr-Phe-Val-OH
Descrição:

Peptide H-GFQSMYTFV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GFQSMYTFV-OH include the following: Adaptive Immune Responses Elicited by Baculovirus and Impacts on Subsequent Transgene Expression In Vivo WY Luo, SY Lin, KW Lo, CH Lu, CL Hung - Journal of , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.03510-12 Luciferase expression allows bioluminescence imaging but imposes limitations on the orthotopic mouse (4T1) model of breast cancer VP Baklaushev , A Kilpelainen, S Petkov - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-07851-z Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging SP Petkov , F Heuts, OA Krotova - Human vaccines & , 2013 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/hv.25561 DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response S Petkov , E Starodubova, A Latanova, A Kilpelainen - PLoS , 2018 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0197902 In vivo bioluminescence imaging in preclinical trials of genetic vaccines S Petkov - 2015 - search.proquest.comhttps://search.proquest.com/openview/9b77e3dbc2d44cf50b967f46e5cd7905/1?pq-origsite=gscholar&cbl=2026366&diss=y CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma R Mezzapelle, F De Marchis, C Passera - EMBO molecular , 2021 - embopress.orghttps://www.embopress.org/doi/abs/10.15252/emmm.202012344 Identification of the murine firefly luciferase-specific CD8 T-cell epitopes MP Limberis, CL Bell, JM Wilson - Gene therapy, 2009 - nature.comhttps://www.nature.com/articles/gt2008177 Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice MDJ Dicks, AJ Spencer , L Coughlan , K Bauza - Scientific reports, 2015 - nature.comhttps://www.nature.com/articles/srep16756 Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model J Leung, P St-Onge, J Stagg, WK Suh - Cancer Immunology , 2017 - Springerhttps://link.springer.com/article/10.1007/s00262-016-1950-2 The immunogenicity in mice of HCV core delivered as DNA is modulated by its capacity to induce oxidative stress and oxidative stress response J Jansons , I Sominskaya , N Petrakova - Cells, 2019 - mdpi.comhttps://www.mdpi.com/2073-4409/8/3/208 Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation EAN Zeeuw van der Laan , S Van Der Velden - Blood , 2020 - ashpublications.orghttps://ashpublications.org/bloodadvances/article-abstract/4/16/3875/463300 Cellular immunogenicity of novel gene immunogens in mice monitored by in vivo imaging E Starodubova, O Krotova, D Hallengard - Molecular , 2012 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.2310/7290.2012.00011 HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist E Bayurova , J Jansons , D Skrastina - Oxidative Medicine , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/6016278 A combination of intradermal jet-injection and electroporation overcomes in vivodose restriction of DNA vaccines D Hallengard, A Braca¥ve, M Isaguliants - Genetic vaccines and , 2012 - Springerhttps://link.springer.com/article/10.1186/1479-0556-10-5 Strategies to enhance the potency of HIV-1 DNA vaccines D Hallengard - 2011 - search.proquest.comhttps://search.proquest.com/openview/9b098717f83c5fc0c03c02528fbf8454/1?pq-origsite=gscholar&cbl=2026366&diss=y

Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:

Propriedades químicas

MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:

Informação sobre riscos

Número ONU:
EQ:
Classe:
Frases H:
Frases P:
Proibido de voar:
Informação sobre riscos:
Grupo de Embalagem:
LQ:

Consulta técnica sobre: 3D-PP43921 H-GFQSMYTFV-OH

Por favor, utilize o carrinho para solicitar um orçamento ou uma encomenda

Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.

* Campos obrigatórios
Bem-vindo à CymitQuimica!Usamos cookies para melhorar sua visita. Não incluímos publicidade.

Consulte a nossa Política de Cookies para mais detalhes ou ajuste suas preferências em "Configurar".